(Q58693945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

review article

1 reference

title

Mitochondrial dysfunction in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

P C Keane

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

M Kurzawa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

P G Blain

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

15 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

716871

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

27 January 2020

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The internal structure of mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Sequence and organization of the human mitochondrial genome

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Cytochrome C-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondria: the hub of cellular Ca2+ signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mechanisms of iron-sulfur protein maturation in mitochondria, cytosol and nucleus of eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Maternal inheritance of human mitochondrial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The organization and inheritance of the mitochondrial genome

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Central nervous system manifestations of mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondria: dynamic organelles in disease, aging, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH–ubiquinone reductase preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial ubiquinone homologues, superoxide radical generation, and longevity in different mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial free radical generation, oxidative stress, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Complex I deficiency in Parkinson's disease frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson's disease: preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Respiratory complex III is required to maintain complex I in mammalian mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I).

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Oxidative DNA damage: mechanisms, mutation, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Protein nitration in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Reactions of O-.2, H2O2 and other oxidants with sulfhydryl enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Alternative excitotoxic hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Bioenergetics and glutamate excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

MPTP as a mitochondrial neurotoxic model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Characterization and distribution of transferrin receptors in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Role of voltage-gated L-type Ca2+ channel isoforms for brain function.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Increased striatal dopamine turnover following acute administration of rotenone to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Nitric oxide neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial calcium transport: mechanisms and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--2. Action potential generating mechanisms and morphological correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial complex I as a novel target for intraneuronal DA: modulation of respiration in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Parkin is protective against proteotoxic stress in a transgenic zebrafish model

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The machines that divide and fuse mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Expression of DJ-1 in the adult mouse CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

DJ-1 has a role in antioxidative stress to prevent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Localization of LRRK2 to membranous and vesicular structures in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

PLA2G6 mutation underlies infantile neuroaxonal dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

PLA2G6 mutations and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Protection of pancreatic beta-cells by group VIA phospholipase A(2)-mediated repair of mitochondrial membrane peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinson's Disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Relationships between Lewy bodies and pale bodies in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Lewy-body formation is an aggresome-related process: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Restricted occurrence of Lewy bodies in the dorsal vagal nucleus in a patient with late-onset parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Diffuse Lewy body disease and progressive dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Pael-R is accumulated in Lewy bodies of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

PINK1 protein in normal human brain and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Proteasome dysfunction in aged human alpha-synuclein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial dysfunction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Environmental risk factors and Parkinson's disease: a case-control study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Acute and persistent parkinsonism after use of diquat

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Piperidine derivatives. Part III. 4-arylpiperidines

21 January 2018

2 references

https://api.crossref.org/works/10.4061%2F2011%2F716871

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

30 November 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Experimental models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

MPTP, MPP+ and mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Competition between paraquat and putrescine for accumulation by rat lung slices

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Paraquat neurotoxicity is distinct from that of MPTP and rotenone.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Complex I is the major site of mitochondrial superoxide production by paraquat

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Synergistic interactions between NADPH-cytochrome P-450 reductase, paraquat, and iron in the generation of active oxygen radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Paraquat- and diquat-induced oxygen radical generation and lipid peroxidation in rat brain microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

DNA damage induces nuclear translocation of parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

The ubiquitin pathway in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F716871

Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

DJ-1, PINK1, and their effects on mitochondrial pathways

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

The parkinsonian toxin MPTP: action and mechanism.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Neurodegenerative disease: amyloid pores from pathogenic mutations.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Environment, mitochondria, and Parkinson's disease

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

In vitro studies of ferritin iron release and neurotoxicity.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Lipid peroxidation as cause of nigral cell death in Parkinson's disease.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

An analysis of the role of coenzyme Q in free radical generation and as an antioxidant

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Filaments of Lewy bodies contain insoluble cytoskeletal elements

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3065167

Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration

30 November 2018

1 reference

12 December 2020

Mitochondrial transcription factor A variants and the risk of Parkinson's disease

1 reference

12 December 2020

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

1 reference

12 December 2020

Neuronal excitotoxicity: the role of mitochondria

1 reference

12 December 2020

Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2, 3,4-tetrahydro-beta-carboline in human blood after intake of the hypnotic chloral hydrate

1 reference

12 December 2020

In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies

1 reference

12 December 2020

Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease

1 reference

12 December 2020

Microsomal membrane peroxidation by an Fe3+/paraquat system. Consequences of phenobarbital induction

1 reference

12 December 2020

Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives

1 reference

12 December 2020

Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats

1 reference

12 December 2020

Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections

1 reference

12 December 2020

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease

1 reference

12 December 2020

1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I

1 reference

12 December 2020

POLG1 in idiopathic Parkinson disease

1 reference

12 December 2020

The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity

1 reference

12 December 2020

An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production

1 reference

12 December 2020

Cerebrospinal fluid levels of superoxide dismutases in neurological diseases detected by sensitive enzyme immunoassays

1 reference

12 December 2020

Inhibition of mitochondrial respiration by analogs of 4-phenylpyridine and 1-methyl-4-phenylpyridinium cation (MPP+), the neurotoxic metabolite of MPTP

1 reference

12 December 2020

Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures

1 reference

12 December 2020

Radical formation site of cerebral complex I and Parkinson's disease

1 reference

12 December 2020

Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide

1 reference

12 December 2020

The halogenated tetrahydro-beta-carboline "TaClo": a progressively-acting neurotoxin

1 reference

12 December 2020

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/716871

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461368%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference